Pharmacologic treatment of eosinophilic esophagitis.
There are several treatment options available for patients who have eosinophilic esophagitis (EE). These options include dilatation for mechanical esophageal abnormalities, pharmacologic therapy, and dietary management. Providing the appropriate therapy depends on the significance of clinical symptoms, association of abnormal anatomy, and histologic involvement of underlying the esophageal tissue. This article focuses on the pharmacotherapy of EE.
Liacouras
Chris A
CA
University of Pennsylvania School of Medicine, 34th and Civic Center Boulevard, Philadelphia, PA 19104, USA. liacouras@email.chop.edu <liacouras@email.chop.edu>
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004802:Eosinophilia / Q000188:drug therapy* / Q000473:pathology; D004804:Eosinophils / Q000473:pathology*; D004941:Esophagitis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000897:Anti-Ulcer Agents; D020024:Leukotriene Antagonists; D054328:Proton Pump Inhibitors